| Literature DB >> 34726580 |
Qian-Qian Du1, Wei Shi1, Dan Yu1, Kai-Hu Yao1.
Abstract
The universal administration of pneumococcal conjugate vaccines (PCVs) had been demonstrated as an effective way to prevent Streptococcus pneumoniae infection. However, the immunity induced by PCVs protected against the infections caused by vaccine serotypes, which were usually more frequent than non-vaccine serotypes (NVTs). The prevalence and pathogenicity of NVTs after universal vaccination have caused widespread concern. We reviewed the epidemiology of non-PCV13 S. pneumoniae before and after PCV13 introduction, and explored the potential reasons for the spread of NVTs. Emerging and spreading NVTs can be regarded as the focus for future serotype epidemiological survey and vaccine optimization.AbbreviationsIPD: invasive pneumococcal disease PCV: pneumococcal conjugate vaccines VT: vaccine serotypeNVT: non-vaccine serotype.Entities:
Keywords: Streptococcus pneumoniae; invasive pneumococcal disease; non-vaccine serotype; pneumococcal conjugate vaccines; serotype replacement
Mesh:
Substances:
Year: 2021 PMID: 34726580 PMCID: PMC8903918 DOI: 10.1080/21645515.2021.1985353
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452